Literature DB >> 28980122

Migraine Treatment in Pregnancy and Lactation.

Anne H Calhoun1,2.   

Abstract

PURPOSE OF REVIEW: Since up to 40.9% of reproductive aged women have migraine-and reproductive-aged women often reproduce-it is essential that we have good information and guidelines regarding proper treatment of migraine during pregnancy and lactation. RECENT
FINDINGS: A review of articles published in the last year on the treatment of migraine during pregnancy and lactation found dishearteningly little. Nevertheless, this article will review the risk/safety information related to migraine treatment in both pregnancy and lactation, citing both new and less recent publications. There is little if any formal research is being carried out on pharmacotherapy for migraine that occurs during pregnancy or lactation. This is likely due to two issues: (1) neurology offers little training in female sex hormones, while gynecology is a surgical field; (2) there is the ever-present concern of litigation if any bad outcome occurs, yet there is no designation of "legally safe" that can be applied to a drug's use in pregnancy and lactation.

Entities:  

Keywords:  Lactation; Migraine; Pregnancy; Treatment

Mesh:

Substances:

Year:  2017        PMID: 28980122     DOI: 10.1007/s11916-017-0646-4

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  28 in total

1.  Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders.

Authors:  Zeyan Liew; Beate Ritz; Cristina Rebordosa; Pei-Chen Lee; Jørn Olsen
Journal:  JAMA Pediatr       Date:  2014-04       Impact factor: 16.193

2.  The incidence and etiology of postpartum headaches: a prospective cohort study.

Authors:  Eric Goldszmidt; Ralph Kern; Alan Chaput; Alison Macarthur
Journal:  Can J Anaesth       Date:  2005-11       Impact factor: 5.063

3.  Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes.

Authors:  Anick Bérard; Shashidhar Kori
Journal:  Headache       Date:  2012-05-21       Impact factor: 5.887

4.  Nonsteroidal antiinflammatory drug use among women and the risk of birth defects.

Authors:  Rohini K Hernandez; Martha M Werler; Paul Romitti; Lixian Sun; Marlene Anderka
Journal:  Am J Obstet Gynecol       Date:  2011-12-01       Impact factor: 8.661

5.  Distribution and excretion of sumatriptan in human milk.

Authors:  R E Wojnar-Horton; L P Hackett; P Yapp; L J Dusci; M Paech; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1996-03       Impact factor: 4.335

6.  Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women.

Authors:  Siri Amundsen; Torunn G Øvrebø; Netta Marie S Amble; Anne Christine Poole; Hedvig Nordeng
Journal:  Eur J Clin Pharmacol       Date:  2016-09-13       Impact factor: 2.953

7.  Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study.

Authors:  K Nezvalová-Henriksen; O Spigset; H Nordeng
Journal:  BJOG       Date:  2013-03-14       Impact factor: 6.531

8.  Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study.

Authors:  De-Kun Li; Liyan Liu; Roxana Odouli
Journal:  BMJ       Date:  2003-08-16

9.  Behavioral sleep modification may revert transformed migraine to episodic migraine.

Authors:  Anne H Calhoun; Sutapa Ford
Journal:  Headache       Date:  2007-09       Impact factor: 5.887

Review 10.  Maternal and fetal effects of acetaminophen and salicylates in pregnancy.

Authors:  E Collins
Journal:  Obstet Gynecol       Date:  1981-11       Impact factor: 7.661

View more
  1 in total

1.  Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020.

Authors:  Henrik W Schytz; Faisal M Amin; Rigmor H Jensen; Louise Carlsen; Stine Maarbjerg; Nunu Lund; Karen Aegidius; Lise L Thomsen; Flemming W Bach; Dagmar Beier; Hanne Johansen; Jakob M Hansen; Helge Kasch; Signe B Munksgaard; Lars Poulsen; Per Schmidt Sørensen; Peter T Schmidt-Hansen; Vlasta V Cvetkovic; Messoud Ashina; Lars Bendtsen
Journal:  J Headache Pain       Date:  2021-04-08       Impact factor: 7.277

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.